How much funding has Radar Therapeutics raised?

Radar Therapeutics has raised $13.4M in total funding, most recently a seed round.

Who are Radar Therapeutics's investors?

Radar Therapeutics's investors include NfX Bio, Eli Lilly and Company, Biovision Ventures, KdT Ventures, Pear VC.

When was Radar Therapeutics founded?

Radar Therapeutics was founded in 2024.

Where is Radar Therapeutics headquartered?

Radar Therapeutics is headquartered in Berkeley, California, United States.

What industry is Radar Therapeutics in?

Radar Therapeutics operates in Biotech, Healthcare.

How many employees does Radar Therapeutics have?

Radar Therapeutics has 1-10 employees.

Radar Therapeutics

The next frontier in medicine

Berkeley, United States · Founded 2024 · $13.4M raised

Biotech

Healthcare

Headquarters: Berkeley, California
Employees: 1–10
Founded: 2024
Business Model: B2B

Website: radartx.bio
Total Funding: $13.4M
Last Round: $13.4M SeedMay 2024
Rounds: 1

About

Radar Therapeutics is a Berkeley, California-based clinical-stage biotechnology company pioneering precision-expressed mRNA-based therapeutics. Founded in 2022 by synthetic biology pioneers Jim Collins, Eerik Kaseniit, and Xiaojing Gao, the company develops programmable mRNA medicines that activate only in the right cell type and at the right time, enabling highly specific genetic interventions for neurological diseases and aging-related conditions. The platform, which emerged from stealth in 2024 with $13.4M in seed funding, offers a new treatment modality distinct from conventional RNA interference or traditional mRNA delivery.

Summary

Radar Therapeutics is a Biotech company based in Berkeley, United States, founded in 2024. It has raised $13.4M in total across 1 round, most recently a $13.4M Seed round in May 2024. Investors include NfX Bio, Eli Lilly and Company and Biovision Ventures.